|
MXCT
Maxcyte, Inc.
MXCT · Q4 FY2023
|
Q4 FY2023 |
|
MXCT Q4 FY2023 transcript
|
|
INVE
Identiv, Inc.
INVE · Q4 FY2023
|
Q4 FY2023 |
|
INVE Q4 FY2023 transcript
|
|
BRT
BRT Apartments Corp.
BRT · Q4 FY2023
|
Q4 FY2023 |
|
BRT Q4 FY2023 transcript
|
|
CSBR
Champions Oncology, Inc.
CSBR · Q3 FY2024
|
Q3 FY2024 |
|
CSBR Q3 FY2024 transcript
|
|
BIRD
Smartbird, Inc.
BIRD · Q4 FY2023
|
Q4 FY2023 |
|
BIRD Q4 FY2023 transcript
|
|
LDI
loanDepot, Inc.
LDI · Q4 FY2023
|
Q4 FY2023 |
|
LDI Q4 FY2023 transcript
|
|
BVS
Bioventus Inc.
BVS · Q4 FY2023
|
Q4 FY2023 |
|
BVS Q4 FY2023 transcript
|
|
SBIG
SpringBig Holdings, Inc.
SBIG · Q4 FY2023
|
Q4 FY2023 |
|
SBIG Q4 FY2023 transcript
|
|
ARQ
Arq, Inc.
ARQ · Q4 FY2023
|
Q4 FY2023 |
|
ARQ Q4 FY2023 transcript
|
|
SKIN
SkinHealth Systems Inc.
SKIN · Q4 FY2023
|
Q4 FY2023 |
|
SKIN Q4 FY2023 transcript
|
|
KSS
KOHLS Corp
KSS · Q4 FY2024
|
Q4 FY2024 |
|
KSS Q4 FY2024 transcript
|
|
QRHC
Quest Resource Holding Corp
QRHC · Q4 FY2023
|
Q4 FY2023 |
|
QRHC Q4 FY2023 transcript
|
|
TLSI
TriSalus Life Sciences, Inc.
TLSI · Q4 FY2023
|
Q4 FY2023 |
|
TLSI Q4 FY2023 transcript
|
|
CORZ
Core Scientific, Inc./tx
CORZ · Q4 FY2023
|
Q4 FY2023 |
|
CORZ Q4 FY2023 transcript
|
|
PRTH
Priority Technology Holdings, Inc.
PRTH · Q4 FY2023
|
Q4 FY2023 |
|
PRTH Q4 FY2023 transcript
|
|
BODI
Beachbody Company, Inc.
BODI · Q4 FY2023
|
Q4 FY2023 |
|
BODI Q4 FY2023 transcript
|
|
ASAN
Asana, Inc.
ASAN · Q4 FY2024
|
Q4 FY2024 |
|
ASAN Q4 FY2024 transcript
|
|
FTEK
Fuel Tech, Inc.
FTEK · Q4 FY2023
|
Q4 FY2023 |
|
FTEK Q4 FY2023 transcript
|
|
OPRX
OptimizeRx Corp
OPRX · Q4 FY2023
|
Q4 FY2023 |
|
OPRX Q4 FY2023 transcript
|
|
FTRE
Fortrea Holdings Inc.
FTRE · Q4 FY2023
|
Q4 FY2023 |
|
FTRE Q4 FY2023 transcript
|
|
ALTO
Alto Ingredients, Inc.
ALTO · Q4 FY2023
|
Q4 FY2023 |
|
ALTO Q4 FY2023 transcript
|
|
SND
Smart Sand, Inc.
SND · Q4 FY2023
|
Q4 FY2023 |
|
SND Q4 FY2023 transcript
|
|
GNE
Genie Energy Ltd.
GNE · Q4 FY2023
|
Q4 FY2023 |
|
GNE Q4 FY2023 transcript
|
|
ORCL
Oracle Corp
ORCL · Q3 FY2024
|
Q3 FY2024 |
|
ORCL Q3 FY2024 transcript
|